Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1,478.15% | -281.36% | -540.76% | -612.25% | 114.65% |
| Total Depreciation and Amortization | 66.88% | 107.31% | 178.69% | 197.17% | 251.58% |
| Total Amortization of Deferred Charges | -- | 400.00% | 100.00% | 131.03% | 257.14% |
| Total Other Non-Cash Items | 110.80% | 101.12% | 112.99% | 94.26% | -11,593.68% |
| Change in Net Operating Assets | -122.19% | -127.71% | -46.87% | 28.41% | 252.04% |
| Cash from Operations | -1.79% | -31.95% | -25.85% | -48.01% | -83.83% |
| Capital Expenditure | 68.80% | 68.93% | 49.46% | -14.23% | -315.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -755.44% | -891.39% | -1,047.74% | -1,381.56% | -315.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.85% | -43.43% | -119.11% | -255.27% | -609.14% |
| Issuance of Common Stock | 336.64% | 4,929.04% | 1,093.20% | 1,377.13% | 2,381.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -774.33% | -352.48% | -100.05% | -100.05% | -100.16% |
| Cash from Financing | 388.81% | 35,054.25% | -95.10% | -95.15% | -95.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.39% | -16.83% | -181.02% | -171.64% | -136.44% |